Cargando…

Second primary malignancies in thyroid cancer patients

The late health effects associated with radioiodine ((131)I) given as treatment for thyroid cancer are difficult to assess since the number of thyroid cancer patients treated at each centre is limited. The risk of second primary malignancies (SPMs) was evaluated in a European cohort of thyroid cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubino, C, de Vathaire, F, Dottorini, M E, Hall, P, Schvartz, C, Couette, J E, Dondon, M G, Abbas, M T, Langlois, C, Schlumberger, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394426/ https://www.ncbi.nlm.nih.gov/pubmed/14583762 http://dx.doi.org/10.1038/sj.bjc.6601319

Ejemplares similares

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
por: Schlumberger, M., et al.
Publicado: (1995)

Second primary malignancies after treatment for malignant lymphoma
por: Okines, A, et al.
Publicado: (2005)

Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment
por: Rubino, C, et al.
Publicado: (2003)

Leukaemias and cancers following iodine-131 administration for thyroid cancer.
por: de Vathaire, F., et al.
Publicado: (1997)

Epidemiological evidence for a common mechanism for neuroblastoma and differentiated thyroid tumour.
por: de Vathaire, F., et al.
Publicado: (1992)

Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer
por: Liou, Miaw-Jene, et al.
Publicado: (2016)

Non-thyroidal second primary malignancy in papillary thyroid cancer patients
por: Borges Duarte, Diana, et al.
Publicado: (2022)

Long-term risk of second malignant neoplasm after a cancer in childhood.
por: de Vathaire, F., et al.
Publicado: (1989)

Radiation exposure and thyroid cancer: a review
por: Iglesias, Maria Laura, et al.
Publicado: (2017)

Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood.
por: de Vathaire, F., et al.
Publicado: (1989)

Survival for endometrial cancer as a second primary malignancy
por: Medina, Heidy N., et al.
Publicado: (2022)

Incidence of second primary malignancies in patients with thyroid cancer in the Turkish population
por: KARAKÖSE, Melia, et al.
Publicado: (2019)

Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
por: Al-Qahtani, Khalid H., et al.
Publicado: (2015)

Second primary malignancies in patients with male breast cancer
por: Hemminki, K, et al.
Publicado: (2005)

Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies
por: Pasqual, Elisa, et al.
Publicado: (2022)

Thyroid Function and Cognition during Aging
por: Bégin, M. E., et al.
Publicado: (2008)

Second malignancies after breast cancer: the impact of different treatment modalities
por: Kirova, Y M, et al.
Publicado: (2008)

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment
por: Vathaire, F de, et al.
Publicado: (1999)

Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes
por: Luo, Xi, et al.
Publicado: (2022)

Primary Malignant Tumours of Bone Following Previous Malignancy
por: Patton, J. T., et al.
Publicado: (2008)

Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine
por: Nocera, M, et al.
Publicado: (2000)

RB1 mutations and second primary malignancies after hereditary retinoblastoma
por: Dommering, Charlotte J., et al.
Publicado: (2011)

Current knowledge and future research directions in treatment-related second primary malignancies
por: Morton, Lindsay M., et al.
Publicado: (2014)

P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING IN MM PATIENTS
por: Avivi, I., et al.
Publicado: (2022)

Deciphering the Risk of Developing Second Primary Thyroid Cancer Following a Primary Malignancy—Who Is at the Greatest Risk?
por: Trinh, Lily N., et al.
Publicado: (2021)

Risk Factors for Nonsynchronous Second Primary Malignancy and Related Death in Patients with Differentiated Thyroid Carcinoma
por: Lang, Brian Hung-Hin, et al.
Publicado: (2011)

Latency Trend Analysis as a Guide to Screening Malignancy Survivors for Second Primary Thyroid Cancer
por: Hussein, Mohammad, et al.
Publicado: (2022)

Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
por: Mora, Barbara, et al.
Publicado: (2019)

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy
por: Pein, F, et al.
Publicado: (2004)

Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors
por: Ory, Catherine, et al.
Publicado: (2011)

Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer
por: Consorti, Fabrizio, et al.
Publicado: (2011)

Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer
por: Zhang, Li, et al.
Publicado: (2016)

Second primary malignancies following salivary gland cancers.
por: Biggar, R. J., et al.
Publicado: (1983)

Second Primary Neoplasms in Thyroid Cancer Patients
por: Ishikawa, Kazuhiro, et al.
Publicado: (1996)

Risk Factors Associated with Benign and Malignant Thyroid Nodules in Autoimmune Thyroid Diseases
por: Lima, Priscila Carneiro Moreira, et al.
Publicado: (2013)

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging
por: Pellegriti, G, et al.
Publicado: (2003)

Chromogranin A and the α -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma
por: Guignat, L, et al.
Publicado: (2001)

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
por: Kim, Hyung Jin, et al.
Publicado: (2023)

Is radioactive iodine- ( 131 ) treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
por: de Souza, Marcelo Cruzick, et al.
Publicado: (2015)

Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
por: Reinecke, Maximilian J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5jqaoffmu3tj1fnd0dvhlab6l1